Who founded Macrotope?

Macrotope was founded by Stephen Anderson, Elliot Campbell.

How much funding has Macrotope raised?

Macrotope has disclosed $900K raised across 3 rounds.

Where is Macrotope headquartered?

Macrotope is headquartered in Princeton, US.

Macrotope

Princeton, US · Delaware corporation

Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.

AI & Machine Learning Biotech Deep Tech Healthtech

Founders & leadership

Stephen AndersoninCo-founder & Chief Executive Officer

Elliot CampbellinCo-founder & Chief Science Officer

Elliot CamptbellNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$900K disclosed across 3 rounds · 2022–2025

▶$400KraisedMay 2025 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Elliot CamptbellExecutive Officer, Director
Stephen AndersonExecutive Officer, Director

Offering amount: $1M
Amount sold: $400K
First sale: May 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$300KraisedAug 2023 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Stephen AndersonExecutive Officer, Director
Elliot CampbellExecutive Officer, Director

Offering amount: $750K
Amount sold: $300K
First sale: Aug 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$200KraisedJun 2022 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Stephen AndersonExecutive Officer, Director
Elliot CampbellDirector

Offering amount: $750K
Amount sold: $200K
First sale: May 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Clasp Therapeutics3 shared keywordsClasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLАre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas. The immuno-oncology company is running a Phase 1 trial (GUARDIAN-101) of its lead candidate CLSP-1025 for hard-to-treat cancers.

Companies competing with Macrotope for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Macrotope do?: Macrotope engineers protein antigens using its patented MacroAntigen/MAV platform, which tunes antigen conformational dynamics to broaden immune response for vaccine and therapeutic antibody discovery. It develops its own vaccine candidates (including for SARS-CoV-2 and related coronaviruses) and offers antibody discovery services to biopharma partners.
Who founded Macrotope?: Macrotope was founded by Stephen Anderson, Elliot Campbell.
How much funding has Macrotope raised?: Macrotope has disclosed $900K raised across 3 rounds.
Where is Macrotope headquartered?: Macrotope is headquartered in Princeton, US.